Brendan Teehan, EVP, COO, Head of Commercial at ACADIA PHARMACEUTICALS INC (ACAD), sold 538 shares at $23.05 ($12K) on 2022-01-06, disclosed to the SEC on 2022-01-10.
Open-market sale of $12k ACAD by EVP, COO, Head of Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2024-05-03 | $118K | — | Filing → |
| ACAD | SELL | 2024-04-09 | $46K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $184K | — | Filing → |